Advertisement

Topics

Seattle Genetics' Adcetris accepted for FDA review

05:50 EDT 17 Aug 2017 | SmartBrief

Seattle Genetics' supplemental biologics license application for Adcetris, or brentuximab vedotin, was accepted for FDA revie -More

Original Article: Seattle Genetics' Adcetris accepted for FDA review

NEXT ARTICLE

More From BioPortfolio on "Seattle Genetics' Adcetris accepted for FDA review"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...